{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:03:10Z","timestamp":1761393790500,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health (CAMH) Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005622","name":"Canadian Institute of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003248","name":"Ontario Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003248","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clinph.2020.05.004","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:06:33Z","timestamp":1589191593000},"page":"1968-1970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improving insight to facilitate antipsychotic medication adherence in patients with schizophrenia"],"prefix":"10.1016","volume":"131","author":[{"given":"Julia","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinph.2020.05.004_b0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2014.03.029","article-title":"Insight facilitation with add-on tDCS in schizophrenia","volume":"156","author":"Bose","year":"2014","journal-title":"Schizophr Res"},{"issue":"11","key":"10.1016\/j.clinph.2020.05.004_b0010","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/ijnp\/pyy074","article-title":"The effects of add-on fronto-temporal transcranial direct current stimulation (tDCS) on auditory verbal hallucinations, other psychopathological symptoms and insight in schizophrenia: a randomized, double-blind, sham-controlled trial","volume":"21","author":"Chang","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.clinph.2020.05.004_b0015","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/hbm.24908","article-title":"Methodology for tDCS integration with fMRI","volume":"41","author":"Esmaeilpour","year":"2020","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"10.1016\/j.clinph.2020.05.004_b0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garc\u00eda","year":"2016","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.clinph.2020.05.004_b0025","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/gps.4154","article-title":"The effects of aging on insight into illness in schizophrenia: a review","volume":"29","author":"Gerretsen","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.clinph.2020.05.004_b0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1192\/bjp.bp.105.019489","article-title":"Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial","volume":"189","author":"Gray","year":"2006","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.clinph.2020.05.004_b0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13696998.2017.1379412","article-title":"Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder","volume":"21","author":"Greene","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.clinph.2020.05.004_b0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/PROM.S42735","article-title":"Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies","volume":"5","author":"Haddad","year":"2014","journal-title":"Patient Relat Outcome Meas"},{"issue":"4","key":"10.1016\/j.clinph.2020.05.004_b0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"10.1016\/j.clinph.2020.05.004_b0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/wps.20060","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry"},{"issue":"8","key":"10.1016\/j.clinph.2020.05.004_b0055","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.clinph.2020.02.029","article-title":"Modulation of self-appraisal of illness, medication adherence, life quality and autonomic functioning by transcranial direct current stimulation in schizophrenia patients","volume":"131","author":"Kao","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"7027","key":"10.1016\/j.clinph.2020.05.004_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.312.7027.345","article-title":"Compliance therapy in psychotic patients: randomised controlled trial","volume":"312","author":"Kemp","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.clinph.2020.05.004_b0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1192\/bjp.172.5.413","article-title":"Randomised controlled trial of compliance therapy. 18-month follow-up","volume":"172","author":"Kemp","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinph.2020.05.004_b0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eurpsy.2019.06.007","article-title":"Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophrenia","volume":"61","author":"Kim","year":"2019","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.clinph.2020.05.004_b0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1192\/bjp.184.6.509","article-title":"Non-adherence to antipsychotic medication regimens: associations with resource use and costs","volume":"184","author":"Knapp","year":"2004","journal-title":"Br J Psychiatry"},{"issue":"10","key":"10.1016\/j.clinph.2020.05.004_b0080","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinph.2020.05.004_b0085","doi-asserted-by":"crossref","unstructured":"Lawrence RE, Dixon L. The challenge of nonadherence in schizophrenia. In: Fornari V, Dancyger I, editors. Psychiatric nonadherence: a solutions-based approach. Cham: Springer International Publishing; 2019 [cited 2020 Apr 29]. p. 43\u201357. Available from: https:\/\/doi.org\/10.1007\/978-3-030-12665-0_4.","DOI":"10.1007\/978-3-030-12665-0_4"},{"issue":"Suppl 5","key":"10.1016\/j.clinph.2020.05.004_b0090","first-page":"3","article-title":"Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia","volume":"67","author":"Leucht","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.clinph.2020.05.004_b0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/schbul\/sbn067","article-title":"Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia","volume":"35","author":"Mohamed","year":"2009","journal-title":"Schizophr Bull"},{"issue":"23","key":"10.1016\/j.clinph.2020.05.004_b0100","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.2174\/1381612821666150619093648","article-title":"Transcranial direct current stimulation for the treatment of refractory symptoms of schizophrenia. Current evidence and future directions","volume":"21","author":"Mondino","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"2\u20133","key":"10.1016\/j.clinph.2020.05.004_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","article-title":"Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia","volume":"176","author":"Novick","year":"2010","journal-title":"Psychiatry Res"},{"issue":"7419","key":"10.1016\/j.clinph.2020.05.004_b0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bmj.327.7419.834","article-title":"Compliance therapy: a randomised controlled trial in schizophrenia","volume":"327","author":"O\u2019Donnell","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clinph.2020.05.004_b0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1176\/appi.ps.57.2.205","article-title":"Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia","volume":"57","author":"Olfson","year":"2006","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.clinph.2020.05.004_b0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajp.2018.08.008","article-title":"High-definition transcranial direct current simulation (HD-tDCS) for persistent auditory hallucinations in schizophrenia","volume":"37","author":"Sreeraj","year":"2018","journal-title":"Asian J Psychiatr"},{"issue":"4","key":"10.1016\/j.clinph.2020.05.004_b0125","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"key":"10.1016\/j.clinph.2020.05.004_b0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ps.52.6.805","article-title":"Using drug claims data to assess the relationship of medication adherence with hospitalization and costs","volume":"52","author":"Svarstad","year":"2001","journal-title":"Psychiatr Serv"},{"issue":"9","key":"10.1016\/j.clinph.2020.05.004_b0135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/ps.2007.58.9.1187","article-title":"Relationships among subjective and objective measures of adherence to oral antipsychotic medications","volume":"58","author":"Velligan","year":"2007","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.clinph.2020.05.004_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jn.00557.2011","article-title":"Combining transcranial direct current stimulation and neuroimaging: novel insights in understanding neuroplasticity","volume":"107","author":"Venkatakrishnan","year":"2012","journal-title":"J Neurophysiol"},{"issue":"2","key":"10.1016\/j.clinph.2020.05.004_b0145","doi-asserted-by":"crossref","first-page":"e55942","DOI":"10.1371\/journal.pone.0055942","article-title":"Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies","volume":"8","author":"Witt","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinph.2020.05.004_b0150","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1176\/appi.ajp.159.10.1653","article-title":"Interventions to improve medication adherence in schizophrenia","volume":"159","author":"Zygmunt","year":"2002","journal-title":"Am J Psychiatry"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245720301711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245720301711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:59:43Z","timestamp":1761393583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245720301711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1388245720301711"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2020.05.004","relation":{},"ISSN":["1388-2457"],"issn-type":[{"type":"print","value":"1388-2457"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving insight to facilitate antipsychotic medication adherence in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2020.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.","name":"copyright","label":"Copyright"}]}}